APA (7th ed.) Citation

Vaz, S. C., Woll, J. P. P., Cardoso, F., Groheux, D., Cook, G. J. R., Ulaner, G. A., . . . de Geus-Oei, L. (2024). Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA). European Journal of Nuclear Medicine & Molecular Imaging, 51(9), 2706. https://doi.org/10.1007/s00259-024-06696-9

Chicago Style (17th ed.) Citation

Vaz, Sofia C., et al. "Joint EANM-SNMMI Guideline on the Role of 2-[18F]FDG PET/CT in No Special Type Breast Cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)." European Journal of Nuclear Medicine & Molecular Imaging 51, no. 9 (2024): 2706. https://doi.org/10.1007/s00259-024-06696-9.

MLA (9th ed.) Citation

Vaz, Sofia C., et al. "Joint EANM-SNMMI Guideline on the Role of 2-[18F]FDG PET/CT in No Special Type Breast Cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)." European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 9, 2024, p. 2706, https://doi.org/10.1007/s00259-024-06696-9.